IRIS PubliCatt

Criscuolo, Marianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.638
EU - Europa 2.395
AS - Asia 898
SA - Sud America 29
AF - Africa 16
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.990
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.622
DE - Germania 888
SE - Svezia 504
CN - Cina 405
SG - Singapore 271
IT - Italia 220
UA - Ucraina 184
IE - Irlanda 126
FR - Francia 114
PL - Polonia 110
ID - Indonesia 83
IN - India 67
FI - Finlandia 55
RU - Federazione Russa 55
GB - Regno Unito 47
TR - Turchia 22
BE - Belgio 18
NL - Olanda 18
CA - Canada 13
BR - Brasile 12
JP - Giappone 12
CI - Costa d'Avorio 11
AU - Australia 10
ES - Italia 9
IR - Iran 8
NO - Norvegia 8
CZ - Repubblica Ceca 7
TH - Thailandia 7
VN - Vietnam 7
CO - Colombia 6
CH - Svizzera 5
AT - Austria 4
CL - Cile 4
AR - Argentina 3
BG - Bulgaria 3
HU - Ungheria 3
IL - Israele 3
KR - Corea 3
LT - Lituania 3
MX - Messico 3
RO - Romania 3
ZA - Sudafrica 3
EC - Ecuador 2
EU - Europa 2
GR - Grecia 2
HK - Hong Kong 2
HR - Croazia 2
MD - Moldavia 2
MY - Malesia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
DK - Danimarca 1
EG - Egitto 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
UY - Uruguay 1
Totale 5.990
Salva come PNG Salva come JPEG
Città #
Chandler 559
Singapore 213
Ashburn 172
Jacksonville 138
Dublin 120
San Mateo 112
Ann Arbor 109
Warsaw 106
Dearborn 96
Woodbridge 94
Houston 93
Nanjing 93
Jakarta 81
Wilmington 79
New York 63
Fairfield 56
Munich 53
Chicago 52
Milan 51
Boston 45
Bremen 44
Moscow 44
Nürnberg 40
Cattolica 38
Seattle 38
Redwood City 37
Nanchang 36
Los Angeles 35
Princeton 34
Lawrence 33
Beijing 25
Hangzhou 23
Marseille 23
Leawood 20
Shenyang 20
Mountain View 19
Shanghai 19
Brussels 18
Cambridge 18
Kunming 17
Chatsworth 16
Redmond 16
Rome 15
Auburn Hills 14
Augusta 14
Falls Church 13
Izmir 13
Pune 13
Zhengzhou 13
Hebei 12
Abidjan 11
Boardman 11
Changsha 11
Norwalk 11
Tianjin 11
Hefei 10
Jiaxing 10
London 10
Guangzhou 9
Jinan 9
University Park 9
Lappeenranta 8
Simi Valley 8
São Paulo 8
Washington 8
Helsinki 7
Philadelphia 7
Brooklyn 6
Edinburgh 6
Enterprise 6
Hanoi 6
Bolzano 5
Frankfurt am Main 5
Fremont 5
Lanzhou 5
Bari 4
Berlin 4
Busto Arsizio 4
Changchun 4
Costa Mesa 4
Groningen 4
Kraków 4
Medellín 4
Paris 4
Sydney 4
Toronto 4
Trieste 4
Vancouver 4
Andover 3
Budapest 3
Cape Town 3
Esslingen am Neckar 3
Gunzenhausen 3
Kish 3
Kocaeli 3
Madrid 3
Mcallen 3
Monmouth Junction 3
Mumbai 3
New Delhi 3
Totale 3.395
Salva come PNG Salva come JPEG
Nome #
Fanconi anemia gene variants in therapy-related myeloid neoplasms 259
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 175
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 139
Why methylation is not a marker predictive of response to hypomethylating agents 137
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 135
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 134
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 133
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 133
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 133
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 128
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 124
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 121
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 118
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 115
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 113
Primary plasma cell leukemia followed by testicular plasmacytoma 113
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 108
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 108
Epigenetic changes in therapy-related MDS/AML 107
Similarities and differences between therapy-related and elderly acute myeloid leukemia 107
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 107
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 104
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 103
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 103
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 101
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 97
Outcome of therapy-related myeloid neoplasms treated with azacitidine 95
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 91
Clonal evolution in therapy-related neoplasms 90
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 86
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 84
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study 80
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 79
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 77
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 76
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 76
High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study 72
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 72
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 70
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 67
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. 66
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes 64
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 64
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 64
Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin 62
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 61
Therapy-related myeloid neoplasms: Clinical perspectives 60
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 59
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 58
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 58
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 58
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 57
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 56
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 56
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS 56
A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group 53
The validity of the fifth and the 10th Body Mass Index percentile as weight cut-offs for anorexia nervosa in adolescence: No evidence from quantitative and network investigation of psychopathology 51
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 51
Systemic mastocytosis revisited with an emphasis on skeletal manifestations 47
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 47
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 46
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 46
Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata 45
Fungaemia in haematological malignancies: SEIFEM-2015 survey 44
Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study 44
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 41
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 36
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 34
Mastocytosis: One Word for Different Diseases 31
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry 26
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope 21
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 19
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study 19
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 16
A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation 15
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review 15
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 15
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 13
Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients 11
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report 10
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 8
Totale 6.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.377
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020550 0 0 0 0 115 138 51 23 60 63 43 57
2020/2021637 27 51 15 46 65 82 83 18 56 53 123 18
2021/2022689 64 39 8 29 51 35 13 122 37 72 94 125
2022/20231.446 185 206 122 267 77 180 50 110 157 20 52 20
2023/2024734 37 185 27 27 29 131 60 15 11 26 90 96
2024/2025443 49 58 128 54 154 0 0 0 0 0 0 0
Totale 6.073